The company has four customers in Europe and is working through FDA approval in the U.S.
Founders
Michael Calhoun, Chris Wood
Company Description
RevealDx develops software aimed at improving the way healthcare professionals diagnose lung cancer, using machine learning techniques to assess the probability that lung nodules found on chest CT scans are cancerous.